Transgene Biotek Balance Sheet Annual

BSE: 526139 | NSE: - | ISIN: INE773D01018 | Sector: Biotechnology & Drugs

6.52 +0.03 (0.46%)Updated : 26 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	0.00	0.00	0.01	0.02
Cash Equivalents	0.01	0.00	0.01	0.01
Cashand Short Term Investments	0.01	0.00	0.02	0.02
Accounts Receivable- Trade Net	0.01	0.01	0.01	0.01
Total Receivables Net	0.01	0.01	0.01	0.01
Total Inventory	0.03	0.03	0.09	0.02
Other Current Assets Total	1.06	0.85	0.58	0.60
Total Current Assets	1.11	0.89	0.70	0.65
Property/ Plant/ Equipment Total- Net	1.67	1.76	1.85	2.03
Intangibles Net	6.55	6.56	11.42	21.16
Long Term Investments	0.10	0.10	0.10	0.00
Note Receivable- Long Term	132.90	132.90	132.90	132.90
Other Long Term Assets Total	0.00	0.15	0.14	0.14
Total Assets	142.33	142.36	147.10	156.88
Accounts Payable	0.20	0.23	0.20	0.11
Notes Payable/ Short Term Debt	8.92	8.16	7.24	0.24
Other Currentliabilities Total	2.02	2.08	1.76	13.83
Total Current Liabilities	11.14	10.47	9.21	14.18
Long Term Debt	5.08	4.95	4.77	4.54
Total Long Term Debt	5.08	4.95	4.77	4.54
Total Debt	14.00	13.11	12.01	4.78
Other Liabilities Total	115.40	115.57	115.75	115.92
Total Liabilities	131.62	130.99	129.72	134.64
Common Stock Total	75.77	75.77	75.77	75.77
Retained Earnings( Accumulated Deficit)	-65.06	-64.40	-58.39	-53.53
Total Equity	10.71	11.37	17.38	22.24
Total Liabilities Shareholders' Equity	142.33	142.36	147.10	156.88
Total Common Shares Outstanding	7.58	7.58	7.58	7.58
Tangible Book Valueper Share Common Eq	0.55	0.63	0.79	0.14